Mark D. Sborov
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 2
- Genetic factors in colorectal cancer 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Thomas M. Habermann (2 shared papers)Matthias Weiss (2 shared papers)Stephen J. Schuster (2 shared papers)Sandra J. Horning (2 shared papers)Sabrina Martín (2 shared papers)Brad S. Kahl (2 shared papers)W. Christopher Ehmann (2 shared papers)Randy D. Gascoyne (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Investigation (1 paper)British Journal of Haematology (1 paper)Clinical Breast Cancer (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Mark D. Sborov
8 papers receiving 255 citations
Peers
Comparison fields: 5 of 35
- Pathology and Forensic Medicine 159
- Genetics 76
- Oncology 155
- Reproductive Medicine 29
- Neurology 30
Countries citing papers authored by Mark D. Sborov
This map shows the geographic impact of Mark D. Sborov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Sborov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Sborov more than expected).
Fields of papers citing papers by Mark D. Sborov
This network shows the impact of papers produced by Mark D. Sborov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Sborov. The network helps show where Mark D. Sborov may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Sborov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 141 | |
| 2 | 2016 | 32 | |
| 3 | 2007 | 28 | |
| 4 | 2008 | 21 | |
| 5 | 2016 | 20 | |
| 6 | 2016 | 13 | |
| 7 | 2012 | 4 | |
| 8 | 2011 | 4 |
About Mark D. Sborov
Mark D. Sborov is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Genetics and General Health Professions, having authored 8 papers that have together received 263 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Viral-associated cancers and disorders (1 paper), Cancer Genomics and Diagnostics (1 paper), Palliative Care and End-of-Life Issues (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (159 citations), Genetics (76 citations), Oncology (155 citations), Reproductive Medicine (29 citations) and Neurology (30 citations). Mark D. Sborov has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Thomas M. Habermann, Matthias Weiss, Stephen J. Schuster, Sandra J. Horning, Sabrina Martín, Brad S. Kahl, W. Christopher Ehmann, Randy D. Gascoyne, John C. Krauss and Lode J. Swinnen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Investigation, British Journal of Haematology, Clinical Breast Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.